2009 Annual Report

• Download PDF (1mb)
• Get Acrobat Reader This link will send you outside of the Cangene website

• Contact info for this section
• Print this page

Research and Development

Cangene's Research and Development group is located in Winnipeg, Manitoba. This group is responsible for developing innovative therapeutic products and technologies. It focuses on early-stage evaluation and development of new products as well as process scale-up, assay development and validation. It also has experience in cloning proteins and antibodies in both bacterial and mammalian cell expression systems.

Bioprocessing and Formulation Group
This group has broad expertise in developing recombinant protein therapeutics through the pre-clinical to licensure phases of a product's lifecycle. This expertise extends to developing and validating purification processes, characterizing proteins using state-of-the-art analytical techniques, and developing and validating analytical assays. In addition, the group has developed a number of lyophilized and liquid formulations for Cangene products.

Product Development Group
This group has extensive knowledge and expertise in cGMP and aseptic manufacturing, process validation, plasma-protein purification, plasma product safety and regulatory compliance in North America and Europe.

The group is composed of scientists and technicians who provide development support in both of Cangene's business sectors.